• 2005

Company Description

Atlas Genetics develops ultra-rapid point-of-care diagnostic tests for infectious diseases, using a novel electrochemical sensor.

Atlas is an innovative UK-based diagnostics company providing in vitro Point-of-Care (POC) testing. Our focus is on diseases such as Sexually Transmitted Infections (STIs), neonatal sepsis and hospital acquired infections, particularly MRSA, where rapid diagnosis is essential for effective treatment and control. We have developed the ultra-rapid io diagnostic platform, a multi-assay system that uses disposable cartridges in conjunction with a small, low cost instrument. This makes it particularly suitable for a wide range of POC settings including doctor’s office, community clinics and specialist primary care clinics. Our aim is to revolutionise patient testing by providing a pioneering, flexible instrument and disposable cartridge system capable of performing nucleic acid, immunoassay and clinical chemistry diagnostics using the same technology platform. By moving diagnostics to POC, Atlas’ io platform can reduce the time between obtaining a patient sample to treatment from up to 10 days to under 30 minutes. We believe that our products will provide doctors and other healthcare professionals with the right tools to enable better patient outcomes. Early and rapid diagnosis of disease in the POC environment ensures the best treatment options are available and POC diagnostics are increasingly recognised as an essential component of more effective primary care. Copyright Atlas. All rights reserved.